Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-10-01
DOI
https://doi.org/10.1093/crocol/otaf065
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Yoshihiro Endo, Shinichiro Shinzaki, Katsuyoshi Matsuoka, Shoko Arai et al.
PubMed
Inflammatory Bowel Disease
article

Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Yoshihiro Endo, Shinichiro Shinzaki, Katsuyoshi Matsuoka, Shoko Arai, Hirotoshi Yuasa, Chihiro Adachi, Keiko Sato, Yasushi Mizuno, Satoshi Motoya, Yohei Mikami, Tadakazu Hisamatsu
article en

Abstract

No abstract available for this paper.
PubMedVol. 7(4)
Toho University (JP), Kyorin University (JP), Keio University (JP), Toho University Medical Center Sakura Hospital (JP), Pfizer (Japan) (JP), Hyogo University (JP)
Good health and well-being
Openalex Percentile: Top 26%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status. — Yoshihiro Endo, Shinichiro Shinzaki, et al. · PubMed (2025) | TGRS Research Map | TGRS